Henry L Gomez

16PUBLICATIONS
120CO-AUTHORS
Cell physiologyEpigenetics (incl. genome methylation and epigenomics)Socio-economic developmentPredictive and prognostic markersMidwifery not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
CA 15.3, Metastatic Burden, and Overall Survival in Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer: Real-World Evidence from Peru.

|Sep 23, 2026
Breast cancer protective genetic variant common in women of Indigenous American genetic ancestry is a cis-eQTL for RMND1, ARMT1, and CCDC170 in HER2-enriched tumor subtypes.

|Sep 03, 2026
Global Disparities in Melanoma Incidence, Mortality, and Mortality-to-Incidence Ratio: An Analytical Framework Using the Human Development Index.

|May 04, 2026
"Carry-Over" Effect of CDK4/6 Inhibitors in Adjuvant Therapy for Hormone Receptor (HR)-Positive/HER2-Negative Early Breast Cancer: Clinical Evidence and Molecular Approach.

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Sep 29, 2025
Decision-Making Patterns for Clinically Node-Positive, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: Insights From a Survey of Breast Cancer Experts.

Yoonwon Kook, Minji Lee, Seung Ho Baek

Pageof 3

Frequent Collaborators

7 joint publications

Tatiana Vidaurre

6 joint publications

Carlos Castañeda

5 joint publications

Guillermo Valencia

5 joint publications

Silvia P Neciosup